NYSE:TGTConsumer Retailing
Did FDA Recall Failures Just Shift Target’s (TGT) Operational Risk Narrative?
Earlier in December 2025, the U.S. FDA issued a warning letter to Target after recalled ByHeart Whole Nutrition Infant Formula linked to an infant botulism outbreak remained on sale in multiple Target stores across 20 states despite recall notices.
The letter highlights not just product safety concerns but also serious weaknesses in Target’s recall execution and regulatory communications, raising questions about its internal controls for high-risk consumer goods.
We’ll now examine how this...